News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
179,179 Results
Type
Article (7302)
Company Profile (117)
Press Release (171756)
Multimedia
Podcasts (73)
Webinars (12)
Section
Business (54073)
Career Advice (374)
Deals (9817)
Drug Delivery (34)
Drug Development (32084)
Employer Resources (74)
FDA (2795)
Job Trends (4234)
News (97011)
Policy (6823)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (260)
Accelerated approval (6)
Adcomms (4)
Allergies (50)
Alliances (12359)
ALS (60)
Alzheimer's disease (489)
Antibody-drug conjugate (ADC) (132)
Approvals (2957)
Artificial intelligence (165)
Autoimmune disease (65)
Automation (10)
Bankruptcy (64)
Best Places to Work (3219)
BIOSECURE Act (16)
Biosimilars (106)
Biotechnology (75)
Bladder cancer (39)
Brain cancer (19)
Breast cancer (153)
Cancer (1550)
Cardiovascular disease (100)
Career advice (345)
Career pathing (29)
CAR-T (105)
CDC (12)
Cell therapy (238)
Cervical cancer (7)
Clinical research (28619)
Collaboration (616)
Compensation (648)
Complete response letters (23)
COVID-19 (698)
CRISPR (21)
C-suite (386)
Cystic fibrosis (38)
Data (2300)
Decentralized trials (1)
Denatured (13)
Depression (61)
Diabetes (124)
Diagnostics (645)
Digital health (9)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (62)
Drug pricing (57)
Drug shortages (3)
Duchenne muscular dystrophy (68)
Earnings (24544)
Editorial (41)
Employer branding (10)
Employer resources (64)
Events (36164)
Executive appointments (446)
FDA (3836)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (447)
Gene editing (44)
Generative AI (17)
Gene therapy (155)
GLP-1 (326)
Government (829)
Grass and pollen (1)
Guidances (138)
Healthcare (2334)
HIV (22)
Huntington's disease (13)
IgA nephropathy (21)
Immunology and inflammation (80)
Immuno-oncology (31)
Indications (43)
Infectious disease (769)
Inflammatory bowel disease (67)
Inflation Reduction Act (8)
Influenza (23)
Intellectual property (88)
Interviews (62)
IPO (5826)
IRA (18)
Job creations (1036)
Job search strategy (267)
JPM (34)
Kidney cancer (8)
Labor market (76)
Layoffs (178)
Leadership (29)
Legal (918)
Liver cancer (31)
Longevity (2)
Lung cancer (263)
Lymphoma (127)
Machine learning (16)
Management (23)
Manufacturing (315)
MASH (103)
Medical device (456)
Medtech (458)
Mergers & acquisitions (4481)
Metabolic disorders (442)
Multiple sclerosis (72)
NASH (8)
Neurodegenerative disease (92)
Neuropsychiatric disorders (34)
Neuroscience (944)
NextGen: Class of 2026 (989)
Non-profit (244)
Now hiring (53)
Obesity (205)
Opinion (110)
Ovarian cancer (49)
Pain (56)
Pancreatic cancer (61)
Parkinson's disease (75)
Partnered (4)
Patents (147)
Patient recruitment (195)
Peanut (19)
People (18021)
Pharmaceutical (36)
Pharmacy benefit managers (5)
Phase 1 (8636)
Phase 2 (13139)
Phase 3 (9642)
Pipeline (2068)
Policy (128)
Postmarket research (510)
Preclinical (3245)
Press Release (19)
Prostate cancer (62)
Psychedelics (19)
Radiopharmaceuticals (127)
Rare diseases (287)
Real estate (1218)
Recruiting (33)
Regulatory (6561)
Reports (28)
Research institute (302)
Resumes & cover letters (43)
RNA editing (4)
RSV (26)
Schizophrenia (105)
Series A (74)
Series B (53)
Service/supplier (4)
Sickle cell disease (23)
Special edition (23)
Spinal muscular atrophy (49)
Sponsored (5)
Startups (978)
State (1)
Stomach cancer (2)
Supply chain (24)
Tariffs (46)
The Weekly (59)
Vaccines (252)
Venture capital (47)
Weight loss (91)
Women's health (19)
Worklife (15)
Date
Today (35)
Last 7 days (218)
Last 30 days (731)
Last 365 days (11079)
2026 (1251)
2025 (11124)
2024 (12550)
2023 (14345)
2022 (16206)
2021 (17842)
2020 (15212)
2019 (10001)
2018 (7149)
2017 (8948)
2016 (7308)
2015 (9302)
2014 (7062)
2013 (5085)
2012 (4915)
2011 (4844)
2010 (4810)
Location
Africa (173)
Alabama (21)
Arizona (27)
Arkansas (2)
Asia (14333)
Australia (1571)
California (4319)
Canada (858)
China (723)
Colorado (161)
Connecticut (177)
Delaware (183)
Europe (25912)
Florida (602)
Georgia (129)
Idaho (4)
Illinois (228)
India (23)
Indiana (142)
Iowa (13)
Japan (175)
Kansas (72)
Kentucky (11)
Louisiana (1)
Maine (2)
Maryland (427)
Massachusetts (3385)
Michigan (48)
Minnesota (129)
Mississippi (2)
Missouri (30)
Montana (2)
Nebraska (6)
Nevada (15)
New Hampshire (7)
New Jersey (1391)
New Mexico (7)
New York (1374)
North Carolina (558)
Northern California (2278)
Ohio (121)
Oklahoma (7)
Oregon (13)
Pennsylvania (747)
Puerto Rico (13)
Rhode Island (11)
South America (212)
South Carolina (6)
Southern California (1656)
Tennessee (16)
Texas (460)
United States (14827)
Utah (91)
Virginia (91)
Washington D.C. (24)
Washington State (273)
West Virginia (1)
Wisconsin (19)
179,179 Results for "umoja biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nona Biosciences Announces Expansion of Collaboration with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies
November 5, 2025
·
3 min read
Press Releases
Umoja Biopharma Named One of 2025’s Most Promising Biotech Companies by Endpoints News and Fierce Biotech
September 24, 2025
·
2 min read
Press Releases
Umoja Biopharma Announces that UB-VV111 Receives FDA Fast Track Designation for Relapsed/Refractory B-Cell Malignancies
October 1, 2025
·
2 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
February 5, 2026
·
1 min read
·
Angela Gabriel
Job Trends
Hiring Plans Show Promise for Biopharma Job Seekers:
BioSpace
Report
More biopharma organizations were actively recruiting at the end of 2025 than 2024, based on the new
BioSpace
employment outlook report. Areas in demand this year include research and development and clinical. Organizations are also prioritizing artificial intelligence hires.
January 29, 2026
·
5 min read
·
Angela Gabriel
JPM
JPM26: Biopharma Projected Positivity in San Francisco. Now It’s Time To Execute
With the biopharma industry performing better of late, analysts, executives and other industry watchers are “cautiously optimistic”—a term heard all over the streets of San Francisco at the J.P. Morgan Healthcare Conference earlier this month.
January 27, 2026
·
6 min read
·
Annalee Armstrong
Business
Umoja Biopharma Announces Appointment of Britton Russell as Chief Financial Officer
Umoja Biopharma, Inc., (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR T cell therapies in oncology and autoimmunity, today announced the appointment of Britton Russell as Chief Financial Officer.
February 28, 2024
·
2 min read
Press Releases
Umoja Biopharma Announces Appointment of Dr. Luke Walker as Chief Medical Officer
January 27, 2025
·
2 min read
Drug Development
Biopharma Momentum To Propel Rare Disease, Cancer, Neuro Forward in 2026
After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told
BioSpace
, with both rare and chronic diseases headlining investor and R&D interest as JPM26 kicks off.
January 12, 2026
·
6 min read
·
Heather McKenzie
BioForest
Umoja Biopharma Announces Publication in Blood Highlighting Successful Generation of In Vivo CAR T-cells in Non-Human Primate Modeling
Umoja Biopharma, Inc. announced that pre-clinical non-human primate data on its VivoVec in vivo CAR T delivery system was published in Blood, the flagship journal of the American Society of Hematology.
June 13, 2024
·
4 min read
1 of 17,918
Next
